LLY

803.38

+2.55%↑

UNH

524.14

+1.24%↑

NVO

135.13

+1.71%↑

JNJ

151.31

-0.09%↓

ABBV

162.99

-0.98%↓

LLY

803.38

+2.55%↑

UNH

524.14

+1.24%↑

NVO

135.13

+1.71%↑

JNJ

151.31

-0.09%↓

ABBV

162.99

-0.98%↓

LLY

803.38

+2.55%↑

UNH

524.14

+1.24%↑

NVO

135.13

+1.71%↑

JNJ

151.31

-0.09%↓

ABBV

162.99

-0.98%↓

LLY

803.38

+2.55%↑

UNH

524.14

+1.24%↑

NVO

135.13

+1.71%↑

JNJ

151.31

-0.09%↓

ABBV

162.99

-0.98%↓

LLY

803.38

+2.55%↑

UNH

524.14

+1.24%↑

NVO

135.13

+1.71%↑

JNJ

151.31

-0.09%↓

ABBV

162.99

-0.98%↓

Search

Merck & Co Inc.

Closed

Sector Healthcare

130.71 -0.18

Overview

Share price change

24h

Current

Min

130.46

Max

132.74

Key metrics

By Trading Economics

Income

-6B

-1.2B

Sales

1.2B

16B

P/E

Sector Avg

60.41

23.904

EPS

2.07

Dividend yield

2.531

Profit margin

-8.38

Employees

72,000

EBITDA

11B

7.5B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+6.55 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.53%

7.76%

Next Earnings

30 Jul 2024

Next Dividend date

8 Jul 2024

Next Ex Dividend date

12 Jun 2024

Market Stats

By TradingEconomics

Market Cap

4.5B

332B

Previous open

130.89

Previous close

130.71

Technical Score

By Trading Central

Confidence

Bearish Evidence

Merck & Co Inc. Chart

Related News

26 Mar 2024, 23:51 UTC

Hot Stocks

Stocks to Watch: GameStop, Merck, Bowman Consulting

26 Mar 2024, 21:52 UTC

Major Market Movers

Merck Shares Rise 5% on FDA Approval for Winrevair

25 Apr 2024, 20:03 UTC

Earnings

Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat -- IBD

25 Apr 2024, 10:31 UTC

Earnings

Merck Adjusts FY View To Adj EPS $8.53-Adj EPS $8.65 >MRK

25 Apr 2024, 10:31 UTC

Earnings

Merck Adjusted Expected FY Worldwide Sales Range to $63.1B-$64.3B >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Pharmaceutical Sales $14.01B >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Pharmaceutical Sales Up 10% >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Keytruda Sales $6.95B >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Keytruda Sales Up 20% >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Gardasil/Gardasil 9 Sales $2.25B >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Januvia/Janumet Sales $670M >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Adj EPS $2.07 >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Januvia/Janumet Sales Down 24% >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Animal Health Sales Up 1% >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Gardasil/Gardasil 9 Sales Up 14% >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q EPS $1.87 >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Net $4.76B >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Animal Health Sales $1.51B >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck Sees FY Adj EPS $8.53-Adj EPS $8.65 >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck 1Q Sales $15.8B >MRK

25 Apr 2024, 10:30 UTC

Earnings

Merck Sees FY Rev $63.1B-$64.3B >MRK

25 Apr 2024, 09:20 UTC

Hot Stocks

Stocks to Watch Thursday: Meta, IBM, Anglo American, Microsoft -- WSJ

4 Apr 2024, 05:00 UTC

Top News

Big Pharma Stocks Need a Rethink. Investors Keep -2-

4 Apr 2024, 05:00 UTC

Top News

Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake. -- Barrons.com

2 Apr 2024, 12:51 UTC

Earnings

Eli Lilly's Ozempic Competitors Face Risks. Why the Stock Has More Upside. -- Barrons.com

27 Mar 2024, 13:51 UTC

Hot Stocks

Stocks to Watch Wednesday: Carnival, Robinhood, Trump Media, Merck -- WSJ

27 Mar 2024, 10:16 UTC

Hot Stocks

Stocks to Watch Wednesday: GameStop, Robinhood, Merck, Carnival -- WSJ

26 Mar 2024, 21:07 UTC

Earnings

Analysts Predict Multibillion-Dollar Annual Sales for New Merck Drug -- WSJ

26 Mar 2024, 21:07 UTC

Earnings

FDA Approves New Merck Drug, Winrevair, for Pulmonary Arterial Hypertension -- WSJ

26 Mar 2024, 21:07 UTC

Top News
Earnings

Merck's $11.5 Billion Bet on Its Next Big Drug Finally Arrives -- WSJ

Peer Comparison

Price change

Merck & Co Inc. Forecast

Price Target

By TipRanks

6.55% upside

12 Months Forecast

Average 139.33 USD  6.55%

High 150 USD

Low 104 USD

Based on 17 Wall Street analysts offering 12 month price targets forMerck & Co Inc. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

17 ratings

14

Buy

2

Hold

1

Sell

Technical Score

By Trading Central

130.38 / 131.51Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Merck & Co Inc.

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.